New and Emerging Tobacco Products and the Nicotine Endgame: The Role of Robust Regulation and Comprehensive Tobacco Control and Prevention: A Presidential Advisory From the American Heart Association

The advent of new tobacco products such as electronic cigarettes and the dramatic rise in their use, especially by adolescents and young adults, are significant public health concerns. Electronic cigarettes have become the most popular tobacco products for youth and adolescents in the United States...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Circulation (New York, N.Y.) Ročník 139; číslo 19; s. e937
Hlavní autori:	Bhatnagar, Aruni, Whitsel, Laurie P, Blaha, Michael J, Huffman, Mark D, Krishan-Sarin, Suchitra, Maa, John, Rigotti, Nancy, Robertson, Rose Marie, Warner, John J
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 07.05.2019
Predmet:	Adolescent American Heart Association Animals Electronic Nicotine Delivery Systems Flavoring Agents Humans Patient Education as Topic Public Health Smoking Cessation Tobacco Products - adverse effects Tobacco Smoking - adverse effects Tobacco Use Disorder - prevention & control United States Young Adult United States nicotine prevention and control tobacco government regulation AHA Scientific Statements
ISSN:	1524-4539, 1524-4539
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	The advent of new tobacco products such as electronic cigarettes and the dramatic rise in their use, especially by adolescents and young adults, are significant public health concerns. Electronic cigarettes have become the most popular tobacco products for youth and adolescents in the United States and are attracting youth to new avenues for nicotine addiction. Although these products may have benefit by helping some smokers quit or to move to a less harmful product, the long-term health effects of these products and the net public health effect associated with their use remain unclear and widely debated. There is increasing concern that the use of newer tobacco products may catalyze transition to the use of other tobacco products or recreational drugs, particularly in young adults. Therefore, there is urgent need for robust US Food and Drug Administration regulation of all tobacco products to avoid the significant economic and population health consequences of continued tobacco use. Although the American Heart Association acknowledges that the ultimate endgame would be an end to all tobacco and nicotine addiction in the United States, it supports first minimizing the use of all combustible tobacco products while ensuring that other products do not addict the next generation of youth and adolescents. The endgame strategy needs to be coordinated with the long-standing, evidence-based tobacco control strategies that have significantly reduced tobacco use and initiation in the United States.
AbstractList	The advent of new tobacco products such as electronic cigarettes and the dramatic rise in their use, especially by adolescents and young adults, are significant public health concerns. Electronic cigarettes have become the most popular tobacco products for youth and adolescents in the United States and are attracting youth to new avenues for nicotine addiction. Although these products may have benefit by helping some smokers quit or to move to a less harmful product, the long-term health effects of these products and the net public health effect associated with their use remain unclear and widely debated. There is increasing concern that the use of newer tobacco products may catalyze transition to the use of other tobacco products or recreational drugs, particularly in young adults. Therefore, there is urgent need for robust US Food and Drug Administration regulation of all tobacco products to avoid the significant economic and population health consequences of continued tobacco use. Although the American Heart Association acknowledges that the ultimate endgame would be an end to all tobacco and nicotine addiction in the United States, it supports first minimizing the use of all combustible tobacco products while ensuring that other products do not addict the next generation of youth and adolescents. The endgame strategy needs to be coordinated with the long-standing, evidence-based tobacco control strategies that have significantly reduced tobacco use and initiation in the United States. The advent of new tobacco products such as electronic cigarettes and the dramatic rise in their use, especially by adolescents and young adults, are significant public health concerns. Electronic cigarettes have become the most popular tobacco products for youth and adolescents in the United States and are attracting youth to new avenues for nicotine addiction. Although these products may have benefit by helping some smokers quit or to move to a less harmful product, the long-term health effects of these products and the net public health effect associated with their use remain unclear and widely debated. There is increasing concern that the use of newer tobacco products may catalyze transition to the use of other tobacco products or recreational drugs, particularly in young adults. Therefore, there is urgent need for robust US Food and Drug Administration regulation of all tobacco products to avoid the significant economic and population health consequences of continued tobacco use. Although the American Heart Association acknowledges that the ultimate endgame would be an end to all tobacco and nicotine addiction in the United States, it supports first minimizing the use of all combustible tobacco products while ensuring that other products do not addict the next generation of youth and adolescents. The endgame strategy needs to be coordinated with the long-standing, evidence-based tobacco control strategies that have significantly reduced tobacco use and initiation in the United States.The advent of new tobacco products such as electronic cigarettes and the dramatic rise in their use, especially by adolescents and young adults, are significant public health concerns. Electronic cigarettes have become the most popular tobacco products for youth and adolescents in the United States and are attracting youth to new avenues for nicotine addiction. Although these products may have benefit by helping some smokers quit or to move to a less harmful product, the long-term health effects of these products and the net public health effect associated with their use remain unclear and widely debated. There is increasing concern that the use of newer tobacco products may catalyze transition to the use of other tobacco products or recreational drugs, particularly in young adults. Therefore, there is urgent need for robust US Food and Drug Administration regulation of all tobacco products to avoid the significant economic and population health consequences of continued tobacco use. Although the American Heart Association acknowledges that the ultimate endgame would be an end to all tobacco and nicotine addiction in the United States, it supports first minimizing the use of all combustible tobacco products while ensuring that other products do not addict the next generation of youth and adolescents. The endgame strategy needs to be coordinated with the long-standing, evidence-based tobacco control strategies that have significantly reduced tobacco use and initiation in the United States.
Author	Maa, John Bhatnagar, Aruni Huffman, Mark D Rigotti, Nancy Robertson, Rose Marie Whitsel, Laurie P Blaha, Michael J Krishan-Sarin, Suchitra Warner, John J
Author_xml	– sequence: 1 givenname: Aruni surname: Bhatnagar fullname: Bhatnagar, Aruni – sequence: 2 givenname: Laurie P surname: Whitsel fullname: Whitsel, Laurie P – sequence: 3 givenname: Michael J surname: Blaha fullname: Blaha, Michael J – sequence: 4 givenname: Mark D surname: Huffman fullname: Huffman, Mark D – sequence: 5 givenname: Suchitra surname: Krishan-Sarin fullname: Krishan-Sarin, Suchitra – sequence: 6 givenname: John surname: Maa fullname: Maa, John – sequence: 7 givenname: Nancy surname: Rigotti fullname: Rigotti, Nancy – sequence: 8 givenname: Rose Marie surname: Robertson fullname: Robertson, Rose Marie – sequence: 9 givenname: John J surname: Warner fullname: Warner, John J
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/30862181$$D View this record in MEDLINE/PubMed
BookMark	eNpNUMtOwzAQtBCIQuEPEPKRS4udOKnDLYpaWglBVZVz5dibYpTYxU6K-EJ-iyQU1L3sa2Z2tJfo1FgDCN1QMqY0pvfZYjUmxxHHyQm6oFHARiwKk9OjeoAuvX_vMOEkOkeDkPA4oJxeoO9n-MTCKDytwG212eK1zYWUFi-dVY2sfb-t3wA_a2lrbQBPjdqKCh7wup2ubAnYFm3OG1_jFWybUtTamp6X2Wrn4A2M13v4l86sqZ0te8TSwR5MR3jAadd5rbpelDhVe-2t-8IzZ6veQtqa1FIYPAfhapx6b6Xur12hs0KUHq4PeYheZ9N1Nh89vTwusvRpJFnMkxHNJwGLJeOCCxa3b5RhDhBPhKAFnxTtgECUKMY5VXmhWE5kIgpGiRSEAg-DIbr71d05-9GArzeV9hLKUhiwjd8ENKGEcBZELfT2AG3yCtRm53Ql3Nfm7_nBD2v4i-A
CitedBy_id	crossref_primary_10_1016_j_cpcardiol_2021_100823 crossref_primary_10_1007_s00592_022_02009_4 crossref_primary_10_2105_AJPH_2025_308031 crossref_primary_10_1161_CIR_0000000000001038 crossref_primary_10_1161_CIR_0000000000001078 crossref_primary_10_3390_jcm12113652 crossref_primary_10_1289_EHP6628 crossref_primary_10_3390_biology10050441 crossref_primary_10_3390_ijerph182413092 crossref_primary_10_1136_tobaccocontrol_2021_056550 crossref_primary_10_1289_EHP14321 crossref_primary_10_1016_j_hrthm_2022_09_021 crossref_primary_10_1161_CIR_0000000000001160 crossref_primary_10_1186_s13256_019_2215_4 crossref_primary_10_1002_prp2_497 crossref_primary_10_1371_journal_pone_0220241 crossref_primary_10_1016_j_pcad_2022_04_007 crossref_primary_10_18332_tid_204789 crossref_primary_10_1088_1361_6528_aba20e crossref_primary_10_1213_ANE_0000000000004508 crossref_primary_10_18332_tid_187302 crossref_primary_10_3390_ijerph18052416 crossref_primary_10_1016_j_addbeh_2023_107631 crossref_primary_10_3389_fpubh_2025_1550045 crossref_primary_10_1161_CIR_0000000000000757 crossref_primary_10_7759_cureus_59934 crossref_primary_10_1161_CIR_0000000000001209 crossref_primary_10_1097_PHH_0000000000001491 crossref_primary_10_1161_CIR_0000000000000950 crossref_primary_10_1093_ntr_ntae238 crossref_primary_10_1016_j_jacc_2021_04_005 crossref_primary_10_1093_eurheartj_ehab245 crossref_primary_10_1161_CIR_0000000000001123 crossref_primary_10_1161_CIRCULATIONAHA_121_056777 crossref_primary_10_4081_jphr_2021_2346 crossref_primary_10_1161_CIR_0000000000001052 crossref_primary_10_3390_ijerph20032078 crossref_primary_10_3389_ijph_2022_1604866 crossref_primary_10_1080_10826084_2025_2537138 crossref_primary_10_1161_CIR_0000000000001293 crossref_primary_10_1093_ntr_ntac180 crossref_primary_10_3390_ijerph17103422 crossref_primary_10_1161_RES_0000000000000544 crossref_primary_10_3390_medicina61030537 crossref_primary_10_1093_ntr_ntae187 crossref_primary_10_1161_CIR_0000000000000967 crossref_primary_10_1016_j_amepre_2019_10_008 crossref_primary_10_1080_10826084_2020_1790010 crossref_primary_10_1161_CIRCULATIONAHA_121_054369 crossref_primary_10_1093_ntr_ntab269 crossref_primary_10_1177_21501319241277393 crossref_primary_10_1016_j_rmcr_2021_101535 crossref_primary_10_3390_ijerph182413035 crossref_primary_10_1007_s41030_025_00305_2 crossref_primary_10_1016_j_amjcard_2020_02_042 crossref_primary_10_1200_GO_25_00034 crossref_primary_10_1007_s00424_023_02824_w crossref_primary_10_1186_s12889_025_22658_8 crossref_primary_10_1016_j_lfs_2021_120255 crossref_primary_10_1161_CIR_0000000000001303 crossref_primary_10_3390_ijerph19106305 crossref_primary_10_1111_ijpo_13190 crossref_primary_10_1161_JAHA_119_012742 crossref_primary_10_1186_s12982_025_00889_9 crossref_primary_10_1016_j_drugalcdep_2020_107855 crossref_primary_10_1080_14737167_2021_1888718 crossref_primary_10_1093_ntr_ntab152 crossref_primary_10_1016_j_toxrep_2025_102100 crossref_primary_10_3390_ijerph17062098 crossref_primary_10_3390_ijerph20032730 crossref_primary_10_1016_j_jacc_2021_09_006
ContentType	Journal Article
DBID	CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1161/CIR.0000000000000669
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	no_fulltext_linktorsrc
Discipline	Medicine Anatomy & Physiology Public Health
EISSN	1524-4539
ExternalDocumentID	30862181
Genre	Journal Article
GeographicLocations	United States
GeographicLocations_xml	– name: United States
GroupedDBID	--- .-D .3C .XZ .Z2 01R 0R~ 0ZK 18M 1J1 29B 2FS 2WC 354 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 6PF 71W 77Y 7O~ AAAAV AAAXR AAGIX AAHPQ AAIQE AAJCS AAMOA AAMTA AAQKA AARTV AASCR AASOK AASXQ AAUEB AAWTL AAXQO ABASU ABBUW ABDIG ABJNI ABOCM ABPMR ABQRW ABVCZ ABXVJ ABZAD ACDDN ACEWG ACGFO ACGFS ACIJW ACILI ACLDA ACOAL ACRKK ACWDW ACWRI ACXJB ACXNZ ADBBV ADCYY ADGGA ADHPY AE3 AE6 AEBDS AENEX AFCHL AFDTB AFEXH AFSOK AFUWQ AGINI AHMBA AHOMT AHQNM AHRYX AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW ASPBG AVWKF AWKKM AYCSE AZFZN BAWUL BOYCO BQLVK BYPQX C45 CGR CS3 CUY CVF DIK DIWNM DU5 E3Z EBS ECM EEVPB EIF EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG GNXGY GQDEL GX1 H0~ HLJTE HZ~ IKREB IKYAY IN~ IPNFZ JF9 JG8 JK3 K-A K-F K8S KD2 KMI KQ8 L-C L7B N9A NPM N~7 N~B O9- OAG OAH OBH OCB ODA ODMTH OGEVE OHH OHYEH OJAPA OK1 OL1 OLB OLG OLH OLU OLV OLW OLY OLZ OPUJH OVD OVDNE OVIDH OVLEI OVOZU OWBYB OWU OWV OWW OWX OWY OWZ OXXIT P2P PQQKQ RAH RHF RIG RLZ S4R S4S T8P TEORI TR2 TSPGW UPT V2I VVN W2D W3M W8F WH7 WOQ WOW X3V X3W XXN XYM YFH YOC YSK YYM YZZ ZFV ZY1 ~H1 7X8 AAFWJ ABPXF ABXYN ABZZY ACDOF ACZKN ADKSD ADSXY AFBFQ AFMBP AFNMH AHQVU AOQMC
ID	FETCH-LOGICAL-c4689-1b7246c48a8a46161c3bee67aa1f87f1610e59d4881dbfd4b0c9af410ca01e832
IEDL.DBID	7X8
ISICitedReferencesCount	76
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000469322900006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1524-4539
IngestDate	Mon Sep 08 12:21:42 EDT 2025 Wed Feb 19 02:31:06 EST 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	19
Keywords	nicotine prevention and control tobacco government regulation AHA Scientific Statements
Language	English
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c4689-1b7246c48a8a46161c3bee67aa1f87f1610e59d4881dbfd4b0c9af410ca01e832
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
OpenAccessLink	https://www.ahajournals.org/doi/pdf/10.1161/CIR.0000000000000669
PMID	30862181
PQID	2191008425
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_2191008425 pubmed_primary_30862181
PublicationCentury	2000
PublicationDate	2019-05-07 20190507
PublicationDateYYYYMMDD	2019-05-07
PublicationDate_xml	– month: 05 year: 2019 text: 2019-05-07 day: 07
PublicationDecade	2010
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Circulation (New York, N.Y.)
PublicationTitleAlternate	Circulation
PublicationYear	2019
SSID	ssj0006375
Score	2.548268
Snippet	The advent of new tobacco products such as electronic cigarettes and the dramatic rise in their use, especially by adolescents and young adults, are...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	e937
SubjectTerms	Adolescent American Heart Association Animals Electronic Nicotine Delivery Systems Flavoring Agents Humans Patient Education as Topic Public Health Smoking Cessation Tobacco Products - adverse effects Tobacco Smoking - adverse effects Tobacco Use Disorder - prevention & control United States Young Adult
Title	New and Emerging Tobacco Products and the Nicotine Endgame: The Role of Robust Regulation and Comprehensive Tobacco Control and Prevention: A Presidential Advisory From the American Heart Association
URI	https://www.ncbi.nlm.nih.gov/pubmed/30862181 https://www.proquest.com/docview/2191008425
Volume	139
WOSCitedRecordID	wos000469322900006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3dS9xAEF_qB-KLttoPtZUplL4tJpd1P3wpx-FhQY_jsHBvx36q4CV6OQX_wv5bzm6S2icpNA8Jm2RCwnzs7MzkN4R8k1oYXnhLhTaCMuEkNdZoKrzUMlNB2ZBwZs_FaCSnUzVuA251W1bZ2cRkqF1lY4z8CDUr4tCgiP24u6exa1TMrrYtNFbIWoGuTJRqMX1BC-dFAtrFKYpRdlyo9tc5dHKOBj8nDXRht3H-ipOZJpvh9v--5luy1bqZ0G_k4h1548sdstsvcYk9f4LvkAo_U0R9h2xctPn1XfIbbR7o0kGMVcX2RXCJ-m5tBeMGGbZOV9FphChCSySC09Jd6bk_AZQ4mFS3HqqAR_NQL2HSdLpH3ie6aHwW_rqpmf_z6EFTLZ_u6BClqvIE-nEUu4niOH6Le4xIoU8wXFTz9ApdtgnOUF2X8JekvSe_hqeXgzPatnqglnGpaG5Ej3HLUEA048ggWxjvudA6D1IEPJH5Y-XQ2uTOBMdMZpUOLM-sznKPVukDWS2r0n8i0CtCMD2OpkUbhvRaScfRk-GiCF7mYY987Tg3Q1WK-RFd-uqhnr3wbo98bNg_u2swP2ZFXPqhN7T_D9QHZBPdKpXKIsVnshbQkPgvZN0-Lm_qxWGSUdyPxhfPU-vzVw
linkProvider	ProQuest
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=New+and+Emerging+Tobacco+Products+and+the+Nicotine+Endgame%3A+The+Role+of+Robust+Regulation+and+Comprehensive+Tobacco+Control+and+Prevention%3A+A+Presidential+Advisory+From+the+American+Heart+Association&rft.jtitle=Circulation+%28New+York%2C+N.Y.%29&rft.au=Bhatnagar%2C+Aruni&rft.au=Whitsel%2C+Laurie+P&rft.au=Blaha%2C+Michael+J&rft.au=Huffman%2C+Mark+D&rft.date=2019-05-07&rft.issn=1524-4539&rft.eissn=1524-4539&rft.volume=139&rft.issue=19&rft.spage=e937&rft_id=info:doi/10.1161%2FCIR.0000000000000669&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1524-4539&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1524-4539&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1524-4539&client=summon